Home Oncimmune Holdings plc

Oncimmune Holdings plc

EarlyCDT Lung Partnership Contract Signed Reports Oncimmune Holdings

With one of the world’s largest pharmaceutical companies, Oncimmune will further evaluate EarlyCDT Lung for the detection of lung cancer in at-risk patients. The initial phase of the collaboration will assess the utility of Early CDT Lung test at detecting incident lung cancer cases in a screening setting.